BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25186993)

  • 1. Skin cancer (Basal cell carcinoma, squamous cell carcinoma, and malignant melanoma): new cases, treatment practice, and health care costs in new brunswick, Canada, 2002-2010.
    Pilgrim W; Hayes R; Hanson DW; Zhang B; Boudreau B; Leonfellner S
    J Cutan Med Surg; 2014 Oct; 18(5):320-31. PubMed ID: 25186993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.
    Hayes RC; Leonfellner S; Pilgrim W; Liu J; Keeling DN
    J Cutan Med Surg; 2007; 11(2):45-52. PubMed ID: 17374314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer).
    Katalinic A; Kunze U; Schäfer T
    Br J Dermatol; 2003 Dec; 149(6):1200-6. PubMed ID: 14674897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
    Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
    Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmelanoma skin carcinoma in Albuquerque, New Mexico: experience of a major health care provider.
    Hoy WE
    Cancer; 1996 Jun; 77(12):2489-95. PubMed ID: 8640697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention.
    Deady S; Sharp L; Comber H
    Br J Dermatol; 2014 Aug; 171(2):324-31. PubMed ID: 24666396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and economic burden of nonmelanoma skin cancer.
    Cakir BÖ; Adamson P; Cingi C
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):419-22. PubMed ID: 23084294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
    Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
    JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
    Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the healthcare costs of skin cancer in South Africa.
    Gordon LG; Elliott TM; Wright CY; Deghaye N; Visser W
    BMC Health Serv Res; 2016 Apr; 16():113. PubMed ID: 27039098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010.
    Rudolph C; Schnoor M; Eisemann N; Katalinic A
    J Dtsch Dermatol Ges; 2015 Aug; 13(8):788-97. PubMed ID: 26213814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of non-melanoma skin cancers in Auckland, New Zealand.
    Pondicherry A; Martin R; Meredith I; Rolfe J; Emanuel P; Elwood M
    Australas J Dermatol; 2018 Aug; 59(3):210-213. PubMed ID: 29350397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.
    Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM
    Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increasing number of skin cancer cases--also among the younger].
    Tarstedt M; Larkö O; Molin L; Wennberg AM
    Lakartidningen; 2005 Jun 27-Jul 10; 102(26-27):1972-5. PubMed ID: 16044750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin cancers in Croatia, 2003-2005: epidemiological study.
    Lipozencić J; Celić D; Strnad M; Toncić RJ; Pasić A; Rados J; Znaor A
    Coll Antropol; 2010 Sep; 34(3):865-9. PubMed ID: 20977074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women.
    Birch-Johansen F; Jensen A; Mortensen L; Olesen AB; Kjær SK
    Int J Cancer; 2010 Nov; 127(9):2190-8. PubMed ID: 20473901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictions of skin cancer incidence in the Netherlands up to 2015.
    de Vries E; van de Poll-Franse LV; Louwman WJ; de Gruijl FR; Coebergh JW
    Br J Dermatol; 2005 Mar; 152(3):481-8. PubMed ID: 15787817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence trends of keratinocytic skin cancers and melanoma in Israel 2006-11.
    Sella T; Goren I; Shalev V; Shapira H; Zandbank J; Rosenblum J; Kimlin MG; Chodick G
    Br J Dermatol; 2015 Jan; 172(1):202-7. PubMed ID: 24976239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the economic costs of skin cancer in New South Wales, Australia.
    Doran CM; Ling R; Byrnes J; Crane M; Searles A; Perez D; Shakeshaft A
    BMC Public Health; 2015 Sep; 15():952. PubMed ID: 26400024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.